Velký výběr
Nabízíme miliony knih v angličtině. Od beletrie až po ty nejodborněji odborné.
ISBN | 9783540776352 |
---|---|
Autor | Gassmann Oliver |
Vydavatel | Springer Nature |
Jazyk | english |
Vazba | Pevná vazba |
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D. Our findings are illustrated not only in cases of Swiss pharmaceutical industry, but also by industry cases from the US and Asia.